Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine and Botox for Post-Operative Pain in Breast Reconstruction
NCT02044302Phase 2Terminated
- Sponsor
- Yale University
- Start
- Apr 2014
- Primary completion
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine, botulinum toxin type A in postoperative pain, sponsored by Yale University. Started Apr 2014; status: terminated.
02
Drugs
bupivacainebotulinum toxin type A
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02044302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02044302.